Skip to main content
    • Aa
    • Aa

Prevalence of pharyngeal and laryngeal complications in adult asthmatics using inhaled corticosteroids

  • R K Bhalla (a1), A S Jones (a1) and N J Roland (a1)

To investigate the prevalence in adults of pharyngeal and laryngeal symptoms associated with the use of inhaled corticosteroids.


Prospective, observational and based on a structured, specifically designed postal questionnaire.


University Hospital Aintree, Liverpool, UK.


The questionnaire was distributed to 190 patients on the basis of current inhaled corticosteroid use. Recruitment was from the databases of two local general practices. Individuals were classified as mild, moderate or severe asthmatics, using the guidelines of the British Thoracic Society.

Main outcome measures:

Demographic data, including smoking history, were recorded. The number, type, strength, dosing regime and duration of individual inhaler use were recorded. Specific pharyngeal and laryngeal side effects were enquired about. Co-morbidities and preventive measures were also recorded. Results were analysed using univariate and multivariate statistical tests.


There was a 75.8 per cent response rate (144/190 questionnaires); 63 (43.8 per cent) of respondents were male and 81 (56.2 per cent) were female. The majority of our patients were either mild or moderate asthmatics. Longer use of an inhaled corticosteroid predisposed to weak voice (p = 0.0016), hoarseness (p = 0.0001) and throat irritation (p = 0.008). Hoarseness, throat irritation, sore throat and cough were observed much more frequently than anticipated. Severe asthmatics were more likely to use a spacer device compliantly (p = 0.0487; odds ratio 1.53). Side effects were more prevalent as asthma severity worsened (p = 0.0049; odds ratio 1.87).


Inhaled corticosteroids cause sore throats, throat irritation, hoarseness and cough. Further research in this area is required in order to elucidate the mechanism of inflammation. Only then can effective preventive measures be introduced and implemented.

Corresponding author
Address for correspondence: Mr R K Bhalla, 17 Withins Hall Road, Woodhouses, Manchester M35 9SA, UK. Fax: +44 (0)151 529 5263 E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1The use of inhaled corticosteroids in adults with asthma. Drug Ther Bull 2000;38:58

2 JH Toogood , RG Crilly , G Jones , J Nadeau , GA Wells . Effect of high-dose inhaled Budesonide on calcium and phosphate metabolism and the risk of osteoporosis. Am Rev Respir Dis 1988;138:5761

3 GE Packe , JG Douglas , AF McDonald , SP Robins , DM Reid . Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax 1992;47:414–17

4 DL Maxwell . Adverse effects of inhaled corticosteroids. Biomed Pharmacother 1990;44:421–7

5 NA Hanania , KR Chapman , S Kesten . Adverse effects of inhaled corticosteroids. Am J Med 1995;98:196208

6 S Capewell , S Reynolds , D Shuttleworth , C Edwards , AY Finlay . Purpura and dermal thinning associated with high dose inhaled corticosteroids. Br Med J 1990;300:1548–51

8 RG Cumming , P Mitchell , SR Leeder . Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997;337:814

9 E Garbe , J LeLorier , J-F Boivin , S Suissa . Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. J Am Med Assoc 1997;277:722–7

10 NJ Roland , RK Bhalla , J Earis . The local side effects of inhaled corticosteroids: current understanding and review of the literature. Chest 2004;126:213–19

11 S Babu , P Samuel . The effect of inhaled steroids on the upper respiratory tract. J Laryngol Otol 1988;102:592–4

12 PJ Barnes , S Pedersen , WW Busse . Efficacy and safety of inhaled corticosteroids. Am J Respir Crit Care Med 1998;157 (3 pt 2):S153

14 N Linder , J Kuint , B German , D Lubin , R Loewenthal . Hypertrophy of the tongue associated with inhaled steroid therapy in premature infants. J Paediatrics 1995;127:651–3

15 AJ Williams , MS Baghat , DE Stableforth , RM Cayton , PM Shenoi , C Skinner . Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax 1983;38:813–21

16 JM DelGaudio . Steroid inhaler laryngitis: dysphonia caused by inhaled fluticasone therapy. Arch Otolaryngol Head Neck Surg 2002;128:677–81

20 O Selroos , R Backman , KO Forsen , AB Lofroos , M Niemisto , A Pietinalho Local side effects during 4-year treatment with inhaled corticosteroids – a comparison between pressurised metered-dose inhalers and Turbohaler. Allergy 1994;49:888–90

21 BJ Lipworth . New perspectives on inhaled drug delivery and systemic bioactivity. Thorax 1995;50:105–10

22Inhaler devices for asthma. Drug Ther Bull 2000;38:914

23 DH Bryant , J Pepys . Bronchial reactions to aerosol inhalant vehicle. Br Med J 1976;1:1319–20

24 C Shim , MH Williams . Cough and wheezing from beclomethasone aerosol. Chest 1987;91:207–9

25 GP Currie , K McLaughlin . The expanding role of leukotriene receptor antagonists in chronic asthma. Ann Allergy Asthma Immunol 2006;97:731–41

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 1
Total number of PDF views: 15 *
Loading metrics...

Abstract views

Total abstract views: 92 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd September 2017. This data will be updated every 24 hours.